Globavir Biosciences, Inc.
Los Altos, USA
|
Globavir Biosciences, Inc. committed to the development of therapeutics and diagnostics for the treatment of global infectious diseases. The company is initially focused on the treatment of dengue virus infection. The company's platform discovery technologies have further identified candidate compounds with efficacy in additional viral indications, including West Nile, Japanese Encephalitis, Ebola, Marburg, and Hunta viruses.